Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mercy Bioanalytics Inc. has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are distributed among 6 distinct examiners. The prosecution involves 4 distinct art units, which indicates that the company's applications are being reviewed by several different specialized groups within the biotechnology sector. This presence in 4 distinct art units shows the technical diversity in the pending portfolio.
CHAN, KO HUNG is identified as the busiest examiner, with 1 busiest examiner pending action. Since there are 6 pending actions and 6 distinct examiners, the workload is spread such that no examiner holds more than 1 busiest examiner pending action. The use of 4 distinct art units for 6 pending actions shows that some art units are handling multiple applications. This distribution suggests a spread prosecution effort where the 6 pending matters are evaluated by a variety of examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (57%) |
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHAN, KO HUNG | 1 | 66.7% | +15.0% |
| WOOLWINE, SAMUEL C | 1 | 61.0% | +20.4% |
| KIM, YOUNG J | 1 | 64.8% | +18.1% |
| DAUNER, JOSEPH G | 1 | 56.9% | +35.2% |
| CASH, KAILEY ELIZABETH | 1 | 28.6% | +64.3% |
| HANEY, AMANDA MARIE | 1 | 36.4% | +44.9% |
| RAMADAN, OMAR | 1 | 25.8% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18580422 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | KIM, YOUNG J | 33d |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | DAUNER, JOSEPH G | — |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | CASH, KAILEY ELIZABETH | — |
| 18580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | HANEY, AMANDA MARIE | — |
| 17435697 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION | RAMADAN, OMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19054047 | COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS | CHAN, KO HUNG | 17d overdue |
| 18580422 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | KIM, YOUNG J | 33d |
| 18580440 | COMPOSITIONS AND METHODS FOR DETECTION OF ESOPHAGEAL CANCER | WOOLWINE, SAMUEL C | — |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | DAUNER, JOSEPH G | — |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | CASH, KAILEY ELIZABETH | — |
| 18580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | HANEY, AMANDA MARIE | — |
| 17435697 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION | RAMADAN, OMAR | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 3631 | 1 |
| 1683 | 1 |
| 1682 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19054047 | COLUMN TUBE HOLDER FOR IMPROVED-ACCURACY ASSAYS | CHAN, KO HUNG | 3631 | §103 | Final Rejection | 17d overdue | Pending | Feb 14, 2025 |
| 18580440 | COMPOSITIONS AND METHODS FOR DETECTION OF ESOPHAGEAL CANCER | WOOLWINE, SAMUEL C | 1681 | §112 | Final Rejection | — | Pending | Jan 18, 2024 |
| 18580422 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | KIM, YOUNG J | 1681 | §101§112 | Final Rejection | 33d | Pending | Jan 18, 2024 |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | DAUNER, JOSEPH G | — | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | CASH, KAILEY ELIZABETH | 1683 | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | HANEY, AMANDA MARIE | 1682 | §101§102§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 17435697 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION | RAMADAN, OMAR | 1678 | §103Other | Non-Final OA | — | Pending | Sep 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial